Diabetes

A daily dose of clinical news on Patient Care you may have missed.

The new policy is helping people who are taking insulin save money and helping others to afford it in the first place, says a study coauthor from the USC Sol Price School of Public Policy .

Reductions in LDL-C, HbA1c, and body weight were associated with a variety of vegetarian diets in participants with or at high risk for cardiovascular disease.

Since 2014, the age-adjusted mortality rate for diabetes and CVD has increased by 1% after an overall decline between 1999 and 2019, new research finds.

The expanded indication widens the patient population eligible for the novel siRNA therapy to include high-risk patients on maximum statin Rx who have not had a CV event.

In a study of over 26 000 participants, statin use was associated with reduced risk for all-cause and CV mortality compared to placebo.

The ADA's annual update includes refined criteria for type 1 diabetes screening and detailed guidance on detection and management of NAFLD and NASH.

KidneyIntelX.dkd, a first-in-class AI-enabled prognostic test, stratifies risk of DKD progression in 5 years and is specific for early stage disease.

Eden Miller, DO, shares key takeaways on how personalized treatment helps in the management of diabetes.

Elizabeth Holt, MD, FACE, and Eden Miller, DO, comment on the pros and cons of real-world data studies, looking particularly at the study of the OneTouch Verio Flex meter and the OneTouch Reveal apps.

Experts discuss steps to introduce the OneTouch Verio Flex meter and the OneTouch Reveal app to patients to better manage diabetes.

ENDO 2023. The pattern of intermittent fasting improved glycemic measures in a weight-independent fashion after just 7 days, according to the study abstract.

Nearly half of responding medical professionals said patients without T2D have asked for an Ozempic Rx and about 18% of them have provided one, avoiding significant backlash for a denial.

Your daily dose of clinical news you may have missed.

Patients with diabetes had a 35% higher risk of COPD compared with those without diabetes, according to new research.

More research is needed to determine whether metformin is also effective in patients with lower body mass index or with previous infection, said researchers.

Eden Miller, DO, reviews the impact the BGM and diabetes management apps have on the patient, giving clinicians a better ability to personalize treatment and empower the patient.

Experts discuss how the amount of time a patient spends engaging with the BGM and diabetes apps will contribute to managing their diabetes.

Reduced risk for 10 different cancers was reported among patients with diabetes treated with SGLT2 inhibitors compared with those not treated.

Your daily dose of clinical news you may have missed.

Results also showed that prediabetes is associated with dementia risk but this risk was explained by the subsequent development of diabetes.

Eden Miller, DO, highlights patient engagement with OneTouch Verio Flex meter and the OneTouch Reveal apps and how the data help to manage diabetes.

Elizabeth Holt, MD, FACE and Eden Miller, DO, review glycemic data over a 90-day and 180-day period in patients with diabetes.

After an acute myocardial infarction, adults with diabetes were over 50% more likely to die after 1 year than those without diabetes, a new study shows.

Your daily dose of clinical news you may have missed.

New study found that patients living in urban areas were more likely to meet all aspects of key metrics of diabetes care.

Experts provide an overview of a study on the use of the OneTouch Verio Flex meter paired with the OneTouch Reveal mobile application in the management of diabetes.

Elizabeth Holt, MD, FACE and Eden Miller, DO, comment on saving time for the provider and giving patients ownership of their data as benefits of using digital BGM apps in the management of diabetes.

Your daily dose of clinical news you may have missed.

Eden Miller, DO, highlights a lack of knowledge in both the patient and the prescriber as a barrier to effective use of BGM technology in diabetes, as well as the need for personalized care for patients.